Affiliation:
1. From the Laboratory of Thrombosis and Atherosclerosis, the Department of Medicine, the Montreal Heart Institute and the University of Montreal, Canada.
Abstract
Background
Smoking is associated with an increased risk of myocardial infarction and sudden death. Platelet activation and thrombosis at sites of vessel stenosis and injury or plaque disruption play a crucial role in these acute coronary events. Thus, the aim of this study was to determine whether cigarette smoking acutely increases platelet thrombus formation on an injured arterial surface at local shear rates typical of a stenotic artery.
Methods and Results
Twelve habitual smokers with stable coronary disease, on aspirin 325 mg/d, were studied immediately before and 5 minutes after smoking two cigarettes each. Ex vivo platelet thrombus formation on porcine arterial media (simulating deep arterial injury) was measured after exposure to the patient’s circulating venous blood for 3 minutes in cylindrical flow chambers at 37°C. The flow chambers were designed to produce shear rates of 754 or 2546 s
−1
, the latter being typical of the high shear rates produced by vessel stenosis. Plasma catecholamine, thromboxane B
2
, and 6-ketoprostaglandin F
1α
(6-keto-PGF
1α
) levels and whole blood platelet aggregation responses to thrombin were also measured before and after smoking. Compared with before smoking, morphometrically measured platelet thrombus formation on arterial media at shear rates of 754 and 2546 s
−1
increased by an average of 48% (
P
=.19) and 64% (
P
=.014), respectively, after smoking. Plasma epinephrine increased by more than twofold after smoking (
P
=.026). Plasma thromboxane B
2
and 6-keto-PGF
1α
levels did not change. Smoking also increased whole blood platelet aggregation to thrombin (
P
≤.05).
Conclusions
These results suggest that smoking-enhanced platelet thrombosis may be an important contributory mechanism for acute coronary events in smokers that is not prevented by aspirin treatment. Catecholamine release and heightened platelet aggregation response to in vivo agonists may contribute to the prothrombotic effects of smoking.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Physiology (medical),Cardiology and Cardiovascular Medicine
Reference25 articles.
1. Coronary heart disease: Epidemiology of smoking and intervention studies of smoking
2. The cardiovascular pathology of smoking
3. Waters D Higginson L Gladstone P Boccuzzi S Cook T Lespérance J for the CCAIT Investigators. Smoking accelerates the progression of coronary atherosclerosis as assessed by serial quantitative coronary arteriography. Circulation . 1993;88(suppl I):I-344. Abstract.
Cited by
217 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献